Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection

Clinical trial NCT02486484 · UNKNOWN

Trial details

NCT number: NCT02486484
Sponsor: Rafic Hariri University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascularization Macular Degeneration Diabetic Retinopathy Retinal Vein Occlusion Choroidal Neovascularization Retinal Neovascularization Recurrent Pterygium Cystoid Macular Edema

Start date: 2015-03-01
Primary completion: 2019-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.